MedPath

Opioid-free Analgesia for the Management of Acute Post-operative Pain Following Caesarean Section

Not Applicable
Completed
Conditions
Acute Post-operative Pain Following Caesarean Section
Interventions
Registration Number
NCT04539249
Lead Sponsor
Olakunle Ifeoluwa Makinde
Brief Summary

Background: Multimodal analgesia; a combination of opioid and non-opioid analgesics, for management of acute post-operative pain significantly reduces the incidence of adverse effects associated with liberal post-operative opioid use including sedation, respiratory depression, constipation, ileus, urinary retention, delayed recovery, addiction etc. However, opioid addiction remains a worsening public health problem and have followed administration of opioid analgesics for post-operative pain and subsequent chronic use in many addicts; especially the opioid naive. Caesarean section is a commonly performed surgery and is a common source of first exposure to opioids in women. Trend in post-operative analgesia is moving towards opioid-free (multimodal) analgesia; a combination of non-opioid and adjuvant analgesics. Magnesium sulphate is an adjuvant analgesic. When administered peri-operatively, it has been reported to prolong the duration of spinal anaesthesia, decrease post-operative pain and opioid use without adverse effect.

Aim: To determine the effectiveness and safety of a combination of peri-operative intravenous magnesium sulphate, intravenous paracetamol, and post-operative rectal diclofenac as opioid-free, multimodal analgesia for management of acute post-operative pain after a caesarean section.

Null Hypothesis: Combination of intravenous magnesium sulphate, intravenous paracetamol, and rectal diclofenac as analgesia regimen for acute post-operative pain after a caesarean section is not as effective and safe as a routine opioid-based multimodal analgesia regimen used in the study setting.

Alternate Hypothesis: Combination of intravenous magnesium sulphate, intravenous paracetamol, and rectal diclofenac as analgesia regimen for acute post-operative pain after a caesarean section is as effective and safe as a routine opioid-based multimodal analgesia regimen used in the study setting.

Materials and Methods: A randomized clinical trial, comparing a combination of peri-operative intravenous magnesium sulphate, intravenous paracetamol, and post-operative rectal diclofenac with an opioid-based multimodal regimen as control. Eligible patients will be consecutively selected from among women booked for caesarean section at the Federal Medical Centre, Yenagoa. Control group will receive a combination of post-operative intramuscular pentazocine, intravenous paracetamol and rectal diclofenac. Pain intensity will be determined in both groups and compared. Need for rescue opioid analgesic will be determined in both groups and compared. Incidence of any adverse event in both groups will be determined.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
324
Inclusion Criteria
  • Pregnant women booked for elective, scheduled and urgent caesarean section at the Federal Medical Centre, Yenagoa, Bayelsa State during the study period,
  • Pregnant women who give consent to participate in the study.
Exclusion Criteria
  • Pregnant women with active peptic ulcer disease, active liver disease, hepatic failure, and renal failure,
  • Pregnant women with previous history of ischaemic heart disease/myocardial infarction, heart failure, venous thrombosis and stroke,
  • Hypersensitivity to pentazocine, paracetamol, diclofenac or magnesium sulphate,
  • Pregnant women with history of non-medical use (abuse) of opioids,
  • Pregnant women on magnesium sulphate or have a clinical indication to receive magnesium sulphate,
  • Pregnant women booked for emergency caesarean section (because the urgency may not allow time for adequate patient counseling before recruitment)
  • Pregnant women booked for caesarean section under general anaesthesia or epidural anaesthesia,
  • Pregnant women who can neither communicate in english nor colloquial english.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Magnesium sulphateMagnesium sulphateCombination of intravenous magnesium sulphate, intravenous paracetamol and rectal diclofenac
PentazocinePentazocineCombination of intramuscular pentazocine, intravenous paracetamol and rectal diclofenac
Primary Outcome Measures
NameTimeMethod
Post-operative Pain Scores Following Caesarean Section at 8 Hours Post-operative8 hours post-operative

Post-operative pain scores following caesarean section at 8 hours post-operative using the Numerical Rating Scale for pain. The Numerical Rating Scale for pain has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a worse outcome (0= No pain at all, 5= Moderate pain and 10= Worst pain imaginable)

Post-operative Pain Scores Following Caesarean Section at 24 Hours Post-operative24 hours post-operative

Post-operative pain scores following caesarean section at 24 hours post-operative using the Numerical Rating Scale for pain. The Numerical Rating Scale for pain has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a worse outcome (0= No pain at all, 5= Moderate pain and 10= Worst pain imaginable)

Post-operative Pentazocine Use24 hours post-operative

Whether or not Pentazocine was used post-operatively

Pentazocine Use as Rescue Analgesia24 hours post-operative

Whether or not pentazocine was used as rescue analgesia

Frequency and Nature of Pentazocine Use24 hours post-operative

Frequency of Pentazocine use per participant in each arm of the study and whether it was used as indicated in the protocol and/or for rescue analgesia

Mean Dose of Pentazocine Used24 hours post-operative

Mean dose of Pentazocine used in each arm of the study

Post-operative Pain Scores Following Caesarean Section at 4 Hours Post-operative4 hours post-operative

Post-operative pain scores following caesarean section at 4 hours post-operative using the Numerical Rating Scale for pain. The Numerical Rating Scale for pain has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a worse outcome (0= No pain at all, 5= Moderate pain and 10= Worst pain imaginable)

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Post-operative Adverse EventsFirst 24 hours post-operative

Number of participants with post-operative adverse events including respiratory depression constipation, ileus, pruritus, urinary retention and any other adverse event recorded during the first 24 hours post-operative.

Number of Participants With Peri-operative Adverse EventsTime of first administration of peri-operative analgesia to 2 hours postoperative

Number of participants with peri-operative adverse events including hypersensitivity reaction, respiratory depression, bradycardia, hypotension, nausea and vomiting, lightheadedness, presyncope, and any other adverse event recorded from the time of first administration of peri-operative analgesia to 2 hours postoperative

Apgar Scores of the NeonatesAt first and fifth minutes after birth

Apgar scores of the neonates delivered by the women who had caesarean section under the study, taken at first and fifth minutes after birth. Apgar score has a minimum score of 0, a maximum score of 10 and a range of 0-10, where higher scores mean a better outcome (0-3= low Apgar score, 4-6= moderately abnormal Apgar score and 7-10= reassuring Apgar score

Trial Locations

Locations (1)

Federal Medical Centre, Yenagoa

🇳🇬

Yenagoa, Bayelsa State, Nigeria

© Copyright 2025. All Rights Reserved by MedPath